Editorial: the most commonly used IBD indices still fail to represent real life and subjective patient experience
- PMID: 32424926
- DOI: 10.1111/apt.15720
Editorial: the most commonly used IBD indices still fail to represent real life and subjective patient experience
Comment in
-
Editorial: the most commonly used IBD indices still fail to represent real life and subjective patient experience. Author's reply.Aliment Pharmacol Ther. 2020 Jun;51(11):1203-1204. doi: 10.1111/apt.15736. Aliment Pharmacol Ther. 2020. PMID: 32424924 No abstract available.
Comment on
-
Bowel damage and disability in Crohn's disease: a prospective study in a tertiary referral centre of the Lémann Index and Inflammatory Bowel Disease Disability Index.Aliment Pharmacol Ther. 2020 May;51(9):889-898. doi: 10.1111/apt.15681. Epub 2020 Mar 27. Aliment Pharmacol Ther. 2020. PMID: 32221985
References
REFERENCES
-
- Lauriot dit Prevost C, Azahaf M, Nachury M et al. Bowel damage and disability in Crohn's disease: a prospective study in a third-line hospital of the Lémann Index and Inflammatory Bowel Disease-Disability Index. Aliment Pharmacol Ther. 202051:889-898. https://doi.org/10.1111/apt.15681.
-
- Food and Drug Administration. Patient-reported outcome measures: use in medical product development to support labelling claims. 2009.
-
- de Jong MJ, Huibregtse R, Masclee AAM, Jonkers DMAE, Pierik MJ. Patient-reported outcome measures for use in clinical trials and clinical practice in inflammatory bowel diseases: a systematic review. Clin Gastroenterol Hepatol. 2018;16:648-663.e3.
-
- Pariente B, Mary JY, Danese S, et al. Development of the Lemann index to assess digestive tract damage in patients with Crohn's disease. Gastroenterology. 2015;148:52-63.e3.
-
- Pariente B, Torres J, Burisch J, et al. OP05 Validation of the Lémann index in Crohns disease. J Crohns Colitis. 2020;14(Suppl. 1):S005-S006.
Publication types
MeSH terms
LinkOut - more resources
Medical